Regular Article
Calpain Inhibitors and Serine Protease Inhibitors Can Produce Apoptosis in HL-60 Cells

https://doi.org/10.1006/abbi.1996.0443Get rights and content

Abstract

Recent investigations indicate that proteolysis is an important event in generation of the apoptosis phenotype. Although various proteases have been suggested to be candidates for this proteolysis, the results from different laboratories are inconsistent. In the present studies, HL-60 cells were treated with cycloheximide to investigate proteases involved in apoptosis. The calpain inhibitors benzyloxycarbonyl-Leu-Leu-Tyr diazomethylketone and acetyl-Leu-Leu-Nle aldehyde were not capable of preventing apoptosis induced by cycloheximide. In the absence of cycloheximide, these two inhibitors could initiate apoptosis in HL-60 cells. The thiol protease inhibitor benzyloxycarbonyl-Leu-Val-Gly diazomethylketone neither prevented nor produced apoptosis. The serine protease inhibitors 3,4-dichloroisocoumarin (DCI) and tosyl-Phe chloromethylketone (TPCK) also induced apoptosis in the absence of cycloheximide. On the other hand, the latter two inhibitors decreased cycloheximide-induced apoptosis, assessed either by cell morphologic changes or DNA ladder generation. Benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone and iodoacetamide, inactivators of interleukin 1β-converting enzyme (ICE)-like proteases, did not produce apoptosis and inhibited the induction of apoptosis by cycloheximide, calpain inhibitors, or serine protease inhibitors. These results are consistent with the ICE-like proteases having a central role in proteolysis during apoptosis, while calpain-like proteases and the serine proteases sensitive to DCI or TPCK are not required for generation of the apoptosis phenotype in HL-60 cells.

References (0)

Cited by (35)

  • Chymotrypsin-like serine proteinases are involved in the maintenance of cell viability

    2012, Biochimie
    Citation Excerpt :

    TPCK, originally designed as an irreversible inhibitor of chymotrypsin has however, been found to impact on apoptosis in a variety of ways which may not be due to its inhibition of serine proteases e.g. TPCK causes the release of pro-apoptotic factors from the mitochondria, can act as efficient direct inhibitors of mature caspases and may interfere with the cell cycle [33,34]. Activation of apoptosis by TPCK also appears to be dependent upon whether apoptotic stimulation is present [33–35]. We found that when co-incubated with staurosporine, an apoptotic inducer, TPCK had a protective effect on HeLa cell viability (data not shown), which is in agreement with O'Connell et al. [36] and King et al. [33].

  • Induction of apoptosis in Eμ-myc lymphoma cells in vitro and in vivo through calpain inhibition

    2012, Experimental Hematology
    Citation Excerpt :

    Previous studies have investigated the use of calpain inhibitors of varying specificity to treat cancer cells in vitro. These include ALLN [22], calpain inhibitor I [42], calpain inhibitor II [23], and aldehyde calpain inhibitors [24]. However, given the similarities in structure among various cysteine proteases, it is not surprising that active site inhibitors have varying degrees of cross-reactivity with other enzymes, such as cathepsins.

  • Role of the calpain-calpastatin system in the density-dependent growth arrest

    2008, Archives of Biochemistry and Biophysics
    Citation Excerpt :

    At concentrations of CI-1 between 0 and 1 μM cell accumulation became similar to that observed in calpastatin transfected cells, promoting 2.5–3 times increase in the density at which cells stop to grow (Fig. 5B, inset). At concentrations of CI-1 higher than 5 μM, a condition providing an almost complete calpain inhibition, cell growth was almost completely arrested, in agreement with previous observations [5,15,16,47,48]. These data indicate that calpain could be required for the transition throughout the cell cycle check points, as well as for favouring the cell entry into the ungrowing G0 stage, both mechanisms probably involved in the regulation of cell proliferation.

  • Protein phosphatase-1 inhibitor-3 is an in vivo target of caspase-3 and participates in the apoptotic response

    2008, Journal of Biological Chemistry
    Citation Excerpt :

    All three agents induced the cleavage of Inh3 as well as PARP (Fig. 2F). Cleavage of Inh3 in Vivo during Apoptosis Is Mediated by Caspase-3—As Inh3 is highly sensitive to proteolysis (18), it could be degraded by other caspases or non-caspase proteases that are activated during apoptosis (e.g. the calpains) (58). In order to obtain further evidence that caspase-3 is the agent for the degradation of Inh3 in vivo during apoptosis, the effects of the caspase-3 inhibitor Z-DEVD-fmk (59) were examined.

View all citing articles on Scopus
1

To whom correspondence and reprint requests should be addressed. Fax: (419) 381-2871. E-mail: [email protected].

View full text